CDC Adviser Says Vote on RSV Antibody Was Based on Distorted Data

‘It appears that this decision was based on manipulated data analyses,’ Dr. Robert Malone said.

Dr. Robert Malone speaks during a meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices at the CDC headquarters in Atlanta on June 25, 2025. Elijah Nouvelage/Getty Images

An adviser to the Centers for Disease Control and Prevention who voted in favor of a respiratory syncytial virus antibody for infants says that new data that has come to light indicates that the vote was based on presentations that omitted crucial information.

“It appears that this decision was based on manipulated data analyses,” Dr. Robert Malone, a member of the CDC’s Advisory Committee on Immunization Practices (ACIP), said in a blog post on Aug. 20.